Overview
- Brady confirmed via a Colossal Biosciences communiqué that Junie was created from a pre‑death blood sample of his dog Lua using the company’s non‑invasive process.
- Colossal announced the news the same day it said it had acquired Viagen Pets and Equine, and Brady is an investor in the Dallas‑based biotech.
- Company materials report about $1,600 to bank an animal’s DNA and up to $50,000 to clone a dog or cat, placing the service in a luxury price range.
- The announcement drew ethical criticism and commentary that the timing functions as marketing tied to Colossal’s expansion into pet cloning.
- Colossal’s broader scientific claims, including 2024 “dire wolf” puppies, face requests for independent verification from bodies such as the IUCN, and experts note clones match genetics but not an animal’s life experience.